March 12 2025 - Eli Lilly CEO David Ricks' pay rose to almost $30 million in 2024

Eli Lilly CEO David Ricks' pay rose to almost $30 million in 2024
Harbour BioMed launches new obesity biotech on mission to preserve muscle mass
Roche builds in obesity with $5.3bn Zealand licensing deal
A once-yearly PrEP? Gilead's lenacapavir shows promise as company plots phase 3
*please scroll down for all the latest news*

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud